Connecting health systems, biopharma companies, and payer communities

FormularyDecisions is a digital platform that supports the exchange of information between healthcare decision makers (HCDMs) and biopharma companies, with the goal of accelerating formulary placement decisions. Registered HCDMs on the platform represent over 288 million pharmacy benefit manager covered lives and more than 1,200 private and public payer organizations across the US.

With FormularyDecisions, HCDMs can access evidence for thousands of products—all from one platform. This includes information on over 3,700 FDA-approved and pipeline products, plus a centralized repository of more than 1 million evidence links to leading scientific resources.* 

The platform enables biopharma companies to share information on their products throughout the product lifecycle and HCDMs to request clinical and economic information from biopharma companies as well as to share their HCDM expertise and insights.  

* Agency for Healthcare Research Quality (AHRQ), American Journal of Health System Pharmacy (AJHP), British Medical Journal (BMJ), Center for Disease Control (CDC), ClinicalTrials.gov (US National Library of Medicine), Cochrane, Institute for Clinical and Economic Review (ICER), JAMA, Journal of Managed Care & Specialty Pharmacy (JMCP), Managed Care, Medscape, National Committee for Quality Assurance (NCQA), National Institute of Mental Health (NIMH), National Institutes of Health (NIH), National Quality Forum, Pharmacist’s Letter, Pharmacy Quality Alliance, PubMed, Reuters, The Medical Letter, UpToDate, US Preventive Services Task Force (UPSTF), Value in Health.